BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 35915507)

  • 1. Therapeutic potential of inhibiting histone 3 lysine 27 demethylases: a review of the literature.
    Abu-Hanna J; Patel JA; Anastasakis E; Cohen R; Clapp LH; Loizidou M; Eddama MMR
    Clin Epigenetics; 2022 Aug; 14(1):98. PubMed ID: 35915507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JMJD3 as an epigenetic regulator in development and disease.
    Burchfield JS; Li Q; Wang HY; Wang RF
    Int J Biochem Cell Biol; 2015 Oct; 67():148-57. PubMed ID: 26193001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysine Demethylase KDM6A in Differentiation, Development, and Cancer.
    Tran N; Broun A; Ge K
    Mol Cell Biol; 2020 Sep; 40(20):. PubMed ID: 32817139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EZH2, JMJD3, and UTX epigenetically regulate hepatic plasticity inducing retro-differentiation and proliferation of liver cells.
    Pediconi N; Salerno D; Lupacchini L; Angrisani A; Peruzzi G; De Smaele E; Levrero M; Belloni L
    Cell Death Dis; 2019 Jul; 10(7):518. PubMed ID: 31285428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases.
    Hong S; Cho YW; Yu LR; Yu H; Veenstra TD; Ge K
    Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18439-44. PubMed ID: 18003914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological targeting of KDM6A and KDM6B, as a novel therapeutic strategy for treating craniosynostosis in Saethre-Chotzen syndrome.
    Pribadi C; Camp E; Cakouros D; Anderson P; Glackin C; Gronthos S
    Stem Cell Res Ther; 2020 Dec; 11(1):529. PubMed ID: 33298158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
    Chang S; Yim S; Park H
    Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysine Demethylase 6B Regulates Prostate Cancer Cell Proliferation by Controlling c-MYC Expression.
    Yıldırım-Buharalıoğlu G
    Mol Pharmacol; 2022 Feb; 101(2):106-119. PubMed ID: 34862309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting histone demethylases JMJD3 and UTX: selenium as a potential therapeutic agent for cervical cancer.
    Chen D; Cai B; Zhu Y; Ma Y; Yu X; Xiong J; Shen J; Tie W; Zhang Y; Guo F
    Clin Epigenetics; 2024 Apr; 16(1):51. PubMed ID: 38576048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic triad epistasis of epigenetic H3K27me modifier genes, EZH2, KDM6A, and KDM6B, in gastric cancer susceptibility.
    Lee SW; Park DY; Kim MY; Kang C
    Gastric Cancer; 2019 May; 22(3):640-644. PubMed ID: 30374835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastoma.
    Lochmann TL; Powell KM; Ham J; Floros KV; Heisey DAR; Kurupi RIJ; Calbert ML; Ghotra MS; Greninger P; Dozmorov M; Gowda M; Souers AJ; Reynolds CP; Benes CH; Faber AC
    Sci Transl Med; 2018 May; 10(441):. PubMed ID: 29769286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H3K27 demethylases are dispensable for activation of Polycomb-regulated injury response genes in peripheral nerve.
    Duong P; Ma KH; Ramesh R; Moran JJ; Won S; Svaren J
    J Biol Chem; 2021 Jul; 297(1):100852. PubMed ID: 34090875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-Ketoglutarate-Dependent KDM6 Histone Demethylases and Interferon-Stimulated Gene Expression in Lupus.
    Montano EN; Bose M; Huo L; Tumurkhuu G; De Los Santos G; Simental B; Stotland AB; Wei J; Bairey Merz CN; Suda J; Martins G; Lalani S; Lawrenson K; Wang Y; Parker S; Venuturupalli S; Ishimori M; Wallace DJ; Jefferies CA
    Arthritis Rheumatol; 2024 Mar; 76(3):396-410. PubMed ID: 37800478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia.
    Li Y; Zhang M; Sheng M; Zhang P; Chen Z; Xing W; Bai J; Cheng T; Yang FC; Zhou Y
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1065-1077. PubMed ID: 29594337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GSK-J4: An H3K27 histone demethylase inhibitor, as a potential anti-cancer agent.
    Dalpatraj N; Naik A; Thakur N
    Int J Cancer; 2023 Sep; 153(6):1130-1138. PubMed ID: 37165737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Distributions of H3K27me3 and its modification enzymes in different tissues of mice].
    Wang Y; Wang X; Zhang R; Zhang Z; Wang Y; Yang B; Wang G; Zhang X; Ma F; Xu H; Wu X; Zhang F; Li Q
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Nov; 33(11):1491-1497. PubMed ID: 29268852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone H3K27me3 demethylases regulate human Th17 cell development and effector functions by impacting on metabolism.
    Cribbs AP; Terlecki-Zaniewicz S; Philpott M; Baardman J; Ahern D; Lindow M; Obad S; Oerum H; Sampey B; Mander PK; Penn H; Wordsworth P; Bowness P; de Winther M; Prinjha RK; Feldmann M; Oppermann U
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6056-6066. PubMed ID: 32123118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Histone H3K27 Demethylases Inactivates Brachyury (TBXT) and Promotes Chordoma Cell Death.
    Cottone L; Cribbs AP; Khandelwal G; Wells G; Ligammari L; Philpott M; Tumber A; Lombard P; Hookway ES; Szommer T; Johansson C; Brennan PE; Pillay N; Jenner RG; Oppermann U; Flanagan AM
    Cancer Res; 2020 Oct; 80(20):4540-4551. PubMed ID: 32855205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade.
    Romero OA; Vilarrubi A; Alburquerque-Bejar JJ; Gomez A; Andrades A; Trastulli D; Pros E; Setien F; Verdura S; Farré L; Martín-Tejera JF; Llabata P; Oaknin A; Saigi M; Piulats JM; Matias-Guiu X; Medina PP; Vidal A; Villanueva A; Sanchez-Cespedes M
    Nat Commun; 2021 Jul; 12(1):4319. PubMed ID: 34262032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate.
    Chakraborty AA; Laukka T; Myllykoski M; Ringel AE; Booker MA; Tolstorukov MY; Meng YJ; Meier SR; Jennings RB; Creech AL; Herbert ZT; McBrayer SK; Olenchock BA; Jaffe JD; Haigis MC; Beroukhim R; Signoretti S; Koivunen P; Kaelin WG
    Science; 2019 Mar; 363(6432):1217-1222. PubMed ID: 30872525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.